LTD4

Ltd4 is a lipid of Fatty Acyls (FA) class. Ltd4 is associated with abnormalities such as Inflammatory Bowel Diseases, Inflammatory disorder, Asthma, Pneumonia and Allergic asthma. The involved functions are known as inhibitors, Signal Transduction, Cell Survival, antagonists and Phosphorylation. Ltd4 often locates in Membrane, Tissue membrane, Protoplasm, Cytoplasmic matrix and membrane fraction. The associated genes with LTD4 are ALOX5 gene, UMOD gene, P4HTM gene, RAF1 gene and Homologous Gene. The related lipids are Lipopolysaccharides.

Cross Reference

Introduction

To understand associated biological information of LTD4, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with LTD4?

LTD4 is suspected in Asthma, Inflammatory Bowel Diseases, Inflammatory disorder, Pneumonia, Allergic asthma, Virus Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with LTD4

MeSH term MeSH ID Detail
Adenocarcinoma D000230 166 associated lipids
Airway Obstruction D000402 13 associated lipids
Asbestosis D001195 8 associated lipids
Aspergillosis, Allergic Bronchopulmonary D001229 2 associated lipids
Asthma D001249 52 associated lipids
Asthma, Exercise-Induced D001250 10 associated lipids
Body Weight D001835 333 associated lipids
Brain Edema D001929 20 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Per page 10 20 50 | Total 39

PubChem Associated disorders and diseases

What pathways are associated with LTD4

Lipid pathways are not clear in current pathway databases. We organized associated pathways with LTD4 through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with LTD4?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with LTD4?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with LTD4?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with LTD4?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with LTD4?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with LTD4

Download all related citations
Per page 10 20 50 100 | Total 640
Authors Title Published Journal PubMed Link
Francis HP et al. The effects of a novel sulphidopeptide leukotriene antagonist, BAY x7195, against elicited bronchoconstriction in the anaesthetized guinea-pig. 1998 Br. J. Pharmacol. pmid:9484852
Hoshino M et al. Leukotriene D4 activates mitogen-activated protein kinase through a protein kinase Calpha-Raf-1-dependent pathway in human monocytic leukemia THP-1 cells. 1998 J. Biol. Chem. pmid:9478929
Fujita M et al. Cysteinyl leukotrienes induce nasal symptoms of allergic rhinitis via a receptor-mediated mechanism in guinea pigs. 1997 Jpn. J. Pharmacol. pmid:9469641
Gorenne I et al. Leukotriene D4 contractions in human airways are blocked by SK&F 96365, an inhibitor of receptor-mediated calcium entry. 1998 J. Pharmacol. Exp. Ther. pmid:9454796
Beckh K et al. Impairment of hepatic transport processes in perfused rat liver by the specific CCK receptor antagonist loxiglumide. 1997 Res Exp Med (Berl) pmid:9406280
Cibulsky SM and Thompson DC Absence of tachykinin involvement in leukotriene D4 and antigen-induced contraction of guinea pig isolated bronchus. 1997 J. Pharmacol. Exp. Ther. pmid:9399982
Kagoshima M et al. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action. 1997 Pharmacology pmid:9380772
Beckh K et al. Effects of nitric oxide on leukotriene D4 decreased bile secretion in the perfused rat liver. 1997 Life Sci. pmid:9364199
Wong WS et al. Effects of tyrosine kinase inhibitors on antigen challenge of guinea pig lung in vitro. 1997 J. Pharmacol. Exp. Ther. pmid:9336317
Spector SL Leukotriene activity modulation in asthma. 1997 Drugs pmid:9279501
Cincu RN et al. S-adenosyl-L-methionine protects the liver against the cholestatic, cytotoxic, and vasoactive effects of leukotriene D4: a study with isolated and perfused rat liver. 1997 Hepatology pmid:9252142
Kanli H and Terreros DA Transepithelial transport and cell volume control in proximal renal tubules from the teleost Carassius auratus. 1997 Acta Physiol. Scand. pmid:9246390
Honda I et al. Tachykinin antagonist FK224 inhibits neurokinin A-, substance P- and capsaicin-induced human bronchial contraction. 1997 Fundam Clin Pharmacol pmid:9243258
O'Shaughnessy TC et al. Effect of pranlukast, an oral leukotriene receptor antagonist, on leukotriene D4 (LTD4) challenge in normal volunteers. 1997 Thorax pmid:9227717
Sampson SE et al. Effect of inhaled prostaglandin D2 in normal and atopic subjects, and of pretreatment with leukotriene D4. 1997 Thorax pmid:9227716
Sakurai S et al. [Synthesis and dual antagonistic activity against thromboxane A2 and leukotriene D4 of benzenesulfonamide derivatives]. 1997 Yakugaku Zasshi pmid:9194397
Meng XJ et al. Leukotriene D4 activates a chloride conductance in hepatocytes from lipopolysaccharide-treated rats. 1997 J. Clin. Invest. pmid:9185515
Sakurai S et al. Synthesis and dual antagonistic activity against thromboxane A2 and leukotriene D4 of [4-[1-(benzenesulfonamido)alkyl]phenyl]alkanoic acid derivatives. 1997 Chem. Pharm. Bull. pmid:9178522
Goldhill J et al. Interleukin-4 modulates cholinergic neural control of mouse small intestinal longitudinal muscle. 1997 Am. J. Physiol. pmid:9176223
Joki S et al. Effect of leukotriene D4 on ciliary activity in human, guinea-pig and rat respiratory mucosa. 1996 Pulm Pharmacol pmid:9160411
Pedersen KE et al. Cysteinyl leukotrienes induce P-selectin expression in human endothelial cells via a non-CysLT1 receptor-mediated mechanism. 1997 J. Pharmacol. Exp. Ther. pmid:9152370
Uno T et al. Participation of leukotriene D4 and tumor necrosis factor on lipopolysaccharide-induced airway hyperresponsiveness in guinea pigs. 1997 Biol. Pharm. Bull. pmid:9145204
Hazel BA et al. Induction of granulocytic differentiation in a mouse model by benzene and hydroquinone. 1996 Environ. Health Perspect. pmid:9118902
Maehr H and Yang R Structure optimization of a leukotriene D4 antagonist by combinatorial chemistry in solution. 1997 Bioorg. Med. Chem. pmid:9113326
Muñoz NM et al. Eosinophil chemotaxis inhibited by 5-lipoxygenase blockade and leukotriene receptor antagonism. 1997 Am. J. Respir. Crit. Care Med. pmid:9105085
Diamant Z et al. The effect of inhaled leukotriene D4 and methacholine on sputum cell differentials in asthma. 1997 Am. J. Respir. Crit. Care Med. pmid:9105062
Zhang MQ and Timmerman H Leukotriene cysLT1 (LTD4) receptor antagonism of H1-antihistamines: an in vitro study. 1997 Inflamm. Res. pmid:9098782
Joki S and Saano V Influence of ageing on ciliary beat frequency and on ciliary response to leukotriene D4 in guinea-pig tracheal epithelium. 1997 Clin. Exp. Pharmacol. Physiol. pmid:9075591
Dumitriu D et al. Mechanism of action of leukotriene D4 on guinea pig tracheal smooth muscle cells: roles of Ca++ influx and intracellular Ca++ release. 1997 J. Pharmacol. Exp. Ther. pmid:9067324
Wang Y et al. Induction of LTD in the dentate gyrus in vitro is NMDA receptor independent, but dependent on Ca2+ influx via low-voltage-activated Ca2+ channels and release of Ca2+ from intracellular stores. 1997 J. Neurophysiol. pmid:9065852
Tvaermose-Nielsen O et al. Discovery of OT4003, a novel, potent, and orally active cys-LT1 receptor antagonist. 1997 Bioorg. Med. Chem. pmid:9061206
Gorenne I et al. Antigen stimulation of human pulmonary smooth muscle: an in vitro model of inflammation. 1996 Cell Biol. Toxicol. pmid:9034615
Kageyama N et al. Role of endogenous nitric oxide in airway microvascular leakage induced by inflammatory mediators. 1997 Eur. Respir. J. pmid:9032485
Kubes P Nitric oxide and microvascular permeability: a continuing dilemma. 1997 Eur. Respir. J. pmid:9032483
Gissurarson SR et al. Effect of lobaric acid on cysteinyl-leukotriene formation and contractile activity of guinea pig taenia coli. 1997 J. Pharmacol. Exp. Ther. pmid:9023290
Aizawa H et al. Thromboxane A2 antagonist inhibits leukotriene D4-induced smooth muscle contraction in guinea-pig lung parenchyma, but not in trachea. 1996 Prostaglandins Leukot. Essent. Fatty Acids pmid:9014223
Brocks DR et al. The single and multiple dose pharmacokinetics of pranlukast in healthy volunteers. 1996 Eur. J. Clin. Pharmacol. pmid:9010703
Pedersen S et al. Leukotriene D4-induced Ca2+ mobilization in Ehrlich ascites tumor cells. 1997 J. Membr. Biol. pmid:9002425
Rajah R et al. Leukotriene D4 induces MMP-1, which functions as an IGFBP protease in human airway smooth muscle cells. 1996 Am. J. Physiol. pmid:8997273
Garcia C et al. Effects of synthetic peptido-leukotrienes on bone resorption in vitro. 1996 J. Bone Miner. Res. pmid:8992883
Bäck M et al. The cysteinyl-leukotriene receptor antagonist BAY u9773 is a competitive antagonist of leukotriene C4 in the guinea-pig ileum. 1996 Eur. J. Pharmacol. pmid:8982726
Nakamura S et al. Effects of 1-[3-(4-benzhydryl-1-piperazinyl)propyl]-3- (1H-imidazol-1-ylmethyl)-1H-indole-6-carboxylic acid with thromboxane A2 synthetase inhibitory and H1-blocking activities on anaphylactic bronchospasm. 1996 Arzneimittelforschung pmid:8955866
Hazel BA and Kalf GF Induction of granulocytic differentiation in myeloblasts by hydroquinone, a metabolite of benzene, involves the leukotriene D4 receptor. 1996 Recept Signal Transduct pmid:8933618
Nagase T et al. Airway and tissue behavior during early response in sensitized rats: role of 5-HT and LTD4. 1996 J. Appl. Physiol. pmid:8929602
Ganbo T et al. The effects of leukotrienes C4 and D4 on ciliary activity of human paranasal sinus mucosa in vitro. 1995 Rhinology pmid:8919211
Kang BC et al. Experimental asthma developed by room air contamination with cockroach allergen. 1996 Int. Arch. Allergy Immunol. pmid:8917126
Nagase T et al. Roles of calcitonin gene-related peptide (CGRP) in hyperpnea-induced constriction in guinea pigs. 1996 Am. J. Respir. Crit. Care Med. pmid:8912779
Gyömber E et al. Effect of lipoxygenase inhibitors and leukotriene antagonists on acute and chronic gastric haemorrhagic mucosal lesions in ulcer models in the rat. 1996 J. Gastroenterol. Hepatol. pmid:8912128
Kaminuma O et al. Inhibitory effect of a novel phosphodiesterase IV inhibitor, T-440, on antigen- and chemical mediator-induced bronchoconstrictions in guinea pigs in vivo. 1996 Jpn. J. Pharmacol. pmid:8902593
Martin CA et al. In vitro pharmacological effects of S 12370 (2-[4-benzhydryloxypiperidinoethyl]isoxindole; an antibronchoconstrictor agent) in normal and sensitized tissue. 1996 Fundam Clin Pharmacol pmid:8902549